Traditional and novel non-statin lipid-lowering drugs
Source : https://pubmed.ncbi.nlm.nih.gov/37979722/
Non-statin drugs find utility in the management of dyslipidaemia in mixed dyslipidaemia, patients with statin intolerance, and when guidelines directed low-density lipoprotein cholesterol (LDL-C) target cannot be achieved despite maximally...
Non-statin drugs are crucial for managing dyslipidaemia in specific patient groups, especially when LDL-C targets are unachievable with statins alone or in cases of statin intolerance.
Share
Effects of Dietary Carbohydrate Concentration and Glycemic Index on Blood Glucose Variability and Free Fatty Acids in Individuals with Type 1 Diabetes
Source : https://pubmed.ncbi.nlm.nih.gov/38732629/
Monitoring glycemic control status is the cornerstone of diabetes management. This study aimed to reveal whether moderate-carbohydrate (CHO) diets increase the risk of free fatty acid (FFA) levels, and it...
In type 1 diabetes, moderate-carbohydrate diets, regardless of glycemic index, did not significantly impact glycemic control but increased free fatty acid and triglyceride levels, potentially elevating cardiovascular risk.
Share
Modulating the Gut Microbiota and Metabolites with Traditional Chinese Medicines: An Emerging Therapy for Type 2 Diabetes Mellitus and Its Complications
Source : https://pubmed.ncbi.nlm.nih.gov/38930814/
Currently, an estimated 537 million individuals are affected by type 2 diabetes mellitus (T2DM), the occurrence of which is invariably associated with complications. Glucose-lowering therapy remains the main treatment for...
Traditional Chinese medicines (TCMs) modulate gut microbiota, restoring host homeostasis and ameliorating metabolic disorders, offering a promising approach for managing type 2 diabetes mellitus and its complications with fewer adverse effects.
Share
Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
Source : https://pubmed.ncbi.nlm.nih.gov/38794747/
Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority...
Vitadio digital therapy is an effective alternative to traditional in-person weight loss programs, demonstrating comparable weight reduction, improved body composition, lipid metabolism, and glycemic control in patients with obesity.
Share
Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity
Source : https://pubmed.ncbi.nlm.nih.gov/38734755/
Sodium-glucose co-transporters type 2 inhibitors (SLGT2i) are highly effective in controlling type 2 diabetes, but reported beneficial cardiovascular effects suggest broader actions on insulin resistance. Weight loss may be initially...
Both metformin and dapagliflozin effectively reduce abdominal fat in type 2 diabetes patients, with combined treatment particularly targeting perirenal fat, suggesting enhanced cardiovascular benefits of dapagliflozin.
Share